The inositols and polycystic ovary syndrome

This review describes the rationale, biochemical, and clinical data related to the use of inositols in polycystic ovary syndrome (PCOS). It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol (MDI), with randomized controlled trials conducted in women with PCOS, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Bharti, Kalra, Sanjay, Sharma, J. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040057/
https://www.ncbi.nlm.nih.gov/pubmed/27730087
http://dx.doi.org/10.4103/2230-8210.189231
_version_ 1782456180438728704
author Kalra, Bharti
Kalra, Sanjay
Sharma, J. B.
author_facet Kalra, Bharti
Kalra, Sanjay
Sharma, J. B.
author_sort Kalra, Bharti
collection PubMed
description This review describes the rationale, biochemical, and clinical data related to the use of inositols in polycystic ovary syndrome (PCOS). It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol (MDI), with randomized controlled trials conducted in women with PCOS, and utilizes these data to suggest pragmatic indications and methods for using MDI combination in PCOS. Rationally crafted inositol combinations have a potential role to play in maintaining metabolic, endocrine, and reproductive health in women with PCOS.
format Online
Article
Text
id pubmed-5040057
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-50400572016-10-11 The inositols and polycystic ovary syndrome Kalra, Bharti Kalra, Sanjay Sharma, J. B. Indian J Endocrinol Metab Brief Communication This review describes the rationale, biochemical, and clinical data related to the use of inositols in polycystic ovary syndrome (PCOS). It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol (MDI), with randomized controlled trials conducted in women with PCOS, and utilizes these data to suggest pragmatic indications and methods for using MDI combination in PCOS. Rationally crafted inositol combinations have a potential role to play in maintaining metabolic, endocrine, and reproductive health in women with PCOS. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5040057/ /pubmed/27730087 http://dx.doi.org/10.4103/2230-8210.189231 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Brief Communication
Kalra, Bharti
Kalra, Sanjay
Sharma, J. B.
The inositols and polycystic ovary syndrome
title The inositols and polycystic ovary syndrome
title_full The inositols and polycystic ovary syndrome
title_fullStr The inositols and polycystic ovary syndrome
title_full_unstemmed The inositols and polycystic ovary syndrome
title_short The inositols and polycystic ovary syndrome
title_sort inositols and polycystic ovary syndrome
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040057/
https://www.ncbi.nlm.nih.gov/pubmed/27730087
http://dx.doi.org/10.4103/2230-8210.189231
work_keys_str_mv AT kalrabharti theinositolsandpolycysticovarysyndrome
AT kalrasanjay theinositolsandpolycysticovarysyndrome
AT sharmajb theinositolsandpolycysticovarysyndrome
AT kalrabharti inositolsandpolycysticovarysyndrome
AT kalrasanjay inositolsandpolycysticovarysyndrome
AT sharmajb inositolsandpolycysticovarysyndrome

Ejemplares similares